![Loading...](https://link.springer.com/static/c4a417b97a76cc2980e3c25e2271af3129e08bbe/images/pdf-preview/spacer.gif)
-
Article
Multicenter evaluation of neoadjuvant and induction gemcitabine–carboplatin versus gemcitabine–cisplatin followed by radical cystectomy for muscle-invasive bladder cancer
Cisplatin-based chemotherapy followed by radical cystectomy (RC) is recommended in patients with muscle-invasive bladder cancer (MIBC). However, up to 50% of patients are cisplatin ineligible. The aim of this ...
-
Article
Open AccessAssociation of age with response to preoperative chemotherapy in patients with muscle-invasive bladder cancer
To assess the association of patient age with response to preoperative chemotherapy in patients with muscle-invasive bladder cancer (MIBC).
-
Article
Hospital volume and 90-day mortality risk after radical cystectomy: a population-based cohort study
Hospital cystectomy volume has been associated with in-hospital perioperative mortality in previous studies. In this study, we examine the relationship between hospital cystectomy volume and 90-day mortality i...
-
Article
Prostate cancer risk stratification by genotype and PSA
The use of PSA testing as a screening tool for prostate cancer is limited by its low specificity. New data offer insight into how genotypic information might be incorporated into PSA screening approaches to en...
-
Article
Quality-of-life assessment in patients with bladder cancer
Surgical treatments for bladder cancer are associated with long-term morbidities that affect bladder and sexual function. This Review on health-related quality of life (HRQOL) examines the important issues sur...